Cadila Pharmaceuticals is an Indian multinational pharmaceutical company based in Ahmedabad. The company's operations focus on manufacturing products ranging from active pharmaceutical intermediates, finished formulations, food supplements, biotechnology products and pharmaceutical machinery.

Revenue(RF), mln.USD
11
Staff(RF), 2021
14
Capital(RF), mln.USD
1
Assets(RF), mln.USD
6
The Company Statement
April 20, 2023

The company continues to work in Russia. Cadila Pharmaceuticals met in 2023 with the Deputy Prime Minister of the Russian Federation and the Minister of International Relations of the Government of Moscow at a powerful bilateral industry round table in New Delhi/ 20224 hsr The Russian Direct Investment Fund (RDIF) and Cadila Pharmaceuticals Ltd., one of the leading private Indian pharmaceutical corporations, have agreed on joint investments in a project to create an innovative pharmaceutical complex and a plant for injectable drugs in Russia.

September 09, 2024LLC "CADILA PHARMACEUTICALS (RUS) LIMITED" - Moscow - General Director Misra Sh. Ch. - INN 9705069706
June 06, 2024RDIF and Indian Cadila Pharmaceuticals invest in construction of pharmaceutical complex in Russia
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner